Thoke Gaurav, Pandiar Deepak, Krishnan Reshma Poothakulath
Department of Oral Pathology and Microbiology, Saveetha Institute of Medical and Technical Sciences, Saveetha Dental College and Hospitals, Saveetha University, Chennai, Tamil Nadu India.
Indian J Otolaryngol Head Neck Surg. 2025 Jul;77(7):2568-2574. doi: 10.1007/s12070-025-05575-5. Epub 2025 May 20.
To apply and correlate clinicopathological parameters and survival in oral squamous cell carcinoma (OSCC) with tumor budding using the modified International Tumor Budding Consensus Conference (ITBCC) criteria for colorectal cancer.
Ethical clearance was sought from the institutional ethical clearance committee, and 121 consecutive cases of excised cases OSCC (with neck dissection and adequate follow-up) were included in the present study. The cases were divided into two groups- with tumor budding (TB) and without TB and were correlated with clinicopathological features. The TB-positive cases were further classified into four classes using modified ITBCC criteria as TB0, TB1, TB2 and TB3. IBM SPSS version 26 was used for analysis, and any value less than or equal to 0.05 was considered statistically significant.
Cases with tumor budding showed more nodal metastasis (p-value: <0.001) and lower overall survival (p-value: 0.038). No significant difference was found between tumor budding and any other clinical and histopathological parameter (p-value: >0.05).
Tumor budding is an independent predictor of nodal metastasis and poorer overall survival in OSCC. Tumor budding at the invasive tumor front should be included in the pathological report and deserves inclusion in staging and grading.
采用改良的国际结直肠癌肿瘤芽生共识会议(ITBCC)标准,将口腔鳞状细胞癌(OSCC)的临床病理参数和生存率与肿瘤芽生情况进行关联分析。
获得机构伦理审查委员会的伦理批准,本研究纳入121例连续的OSCC切除病例(伴有颈部清扫和充分随访)。病例分为两组——有肿瘤芽生(TB)组和无肿瘤芽生组,并与临床病理特征进行关联分析。TB阳性病例根据改良的ITBCC标准进一步分为TB0、TB1、TB2和TB3四类。采用IBM SPSS 26版进行分析,任何小于或等于0.05的值被认为具有统计学意义。
有肿瘤芽生的病例显示出更多的淋巴结转移(p值:<0.001)和更低的总生存率(p值:0.038)。肿瘤芽生与任何其他临床和组织病理学参数之间未发现显著差异(p值:>0.05)。
肿瘤芽生是OSCC淋巴结转移和总生存率较差的独立预测因素。侵袭性肿瘤前沿的肿瘤芽生情况应包含在病理报告中,并且值得纳入分期和分级。